Healthcare -
Biotechnology - NASDAQ - US
$ 15.135
-2.29 %
$ 1.28 B
Market Cap
-9.34
P/E
LQDA - REVENUE
Revenue LQDA - Liquidia Corporation
17.5 M
LAST VALUE
16.64%
2 YEAR CAGR
45.23%
5 YEAR CAGR
0.00%
10 YEAR CAGR